NovoCure OverviewNovoCure Other Income Expense Net
Other Income/Expense Net for NVCR.
Quarterly Other Income/Expense
-$1.84M
↓ 124.28% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$8.14M
↓ 78.03% YoY
Trailing 12 months ending Mar 31, 2026